1. 1. Friedländer C. 1882. Ueber die Schizomyceten bei der acuten fibrösen Pneumonie. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 87:319-324. 2. Paczosa MK, Mecsas J. 2016. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiology and Molecular Biology Reviews 80:629-661. 3. Bengoechea JA, Sa Pessoa J. 2019. Klebsiella pneumoniae infection biology: living to counteract host defences. FEMS microbiology reviews 43:123-144. 4. Taghinejad J, Barati B, Sadeghi A. 2018. A study of the drug resistance pattern of Group B Streptococcus isolated from urinary samples in the city of Salmas during the year 2015. New Cellularand Molecular Biotechnology Journal 8:79-84. 5. Mehdi RM, Javid T, Hossein MA. Drug susceptibility of E. coli strains isolated from patients with UTI by disc diffusion agar method in Salmas city of Iran. HealthMED:1146. 6. Taghinejad J, Barati B, Sadeghi A. A study of the drug resistance pattern of Group B Streptococcus isolated from urinary samples in the city of Salmas during the year 2015. NCMBJ. 2018
2. 8 (30):79-84 (Persian). 7. Wei J, Wenjie Y, Ping L, Na W, Haixia R, Xuequn Z. 2018. Antibiotic resistance of Klebsiella pneumoniae through β-arrestin recruitment-induced β-lactamase signaling pathway. Experimental and therapeutic medicine 15:2247-2254. 8. Zaniani FR, Meshkat Z, Nasab MN, Khaje-Karamadini M, Ghazvini K, Rezaee A, Esmaily H, Nabavinia MS, Hoseini MD. 2012. The prevalence of blaTEM and blaSHV genes among extended-spectrum beta-lactamases producing Escherichia coli and Klebsiella pneumoniae. Iranian journal of basic medical sciences 15:654. 9. Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanés C. 2001. SHV-1 β-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 45:2856-2861. 10. Hudzicki J. 2009. Kirby-Bauer disk diffusion susceptibility test protocol. American Society for Microbiology. 11. CLSI. 2018. Performance Standards for Antimicrobial Disk Susceptibility Tests, 13th Edition. CLSI standard M02 Wayne, PA: Clinical and Laboratory Standards Institute. 12. Wadekar MD, Anuradha K, Venkatesha D. 2013. Phenotypic detection of ESBL and MBL in clinical isolates of Enterobacteriaceae. Int J Curr Res Aca Rev 1:89-95. 13. Ahmed OB, Dablool A. 2017. Quality improvement of the DNA extracted by boiling method in gram negative bacteria. International Journal of Bioassays 6. 14. Mobin H, Nahaie MR, Amir mozafari N, Sadeghi J, M R. 2007. Enterobacteriaceae producing Extended-spectrum beta-lactamases (ESBL) and plasmid patterns in intensive care unit of children's hospital in Tabriz. Med J Tabriz Univ Med Sci 28:95-101. 15. Soroush Z, Ghane M. 2017. Molecular identification of blaCTX-M, blaTEM and blaSHV beta-lactamases in â Klebsiella pneumoniae isolated from respiratory system of patients in the ICU of educational hospitals in Tehran. Feyz Journal of Kashan University of Medical Sciences 21:232-239. 16. Talebi TM, Golestanpour A. 2009. Symptomatic nosocomial urinary tract infection in ICU patients: identification of antimicrobial resistance pattern. 17. Archin T, Afzalian E, Kargar M, Y G. 2014. β lactamases genes and antibiotics resistance pattern of K. pneumoniae isolates collected from ICU patients of Namazi Hospital, Shiraz, Iran. Armaghan-e-Danesh 18:816-25. 18. Derakhshan S, Najar peerayeh F, Fallah F, Bakhshi B, Rahbar M, M. M-Z. 2013. Identification of expended spectrum betalactamase producing Klebsiella pneumonia isolated from intensive care unit (ICU) patiants in three hospitals in Iran. Infect Epidemiol Med 1:9-13. 19. Ahmed OB, Omar AO, Asghar AH, Elhassan MM, Al-Munawwarah A-M, Arabia S. 2013. Prevalence of blaTEM, blaSHV and blaCTX-M genes in Escherichia coli and Klebsiella spp Urinary Isolates from Sudan with confirmed ESBL phenotype. Life Sci J 10:191-5. 20. Ghafourian S, bin Sekawi Z, Sadeghifard N, Mohebi R, Neela VK, Maleki A, Hematian A, Rahbar M, Raftari M, Ranjbar R. 2011. The prevalence of ESBLs producing Klebsiella pneumoniae isolates in some major hospitals, Iran. The open microbiology journal 5:91. 21. Goyal A, Prasad K, Prasad A, Gupta S, Ghoshal U, Ayyagari A. 2009. Extended spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae and associated risk factors. Indian J Med Res 129:695-700. 22. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. 2009. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. Brazilian Journal of Infectious Diseases 13:403-407. 23. Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y. 2009. Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. Journal of medical microbiology 58:912-922. 24. Lartigue M-F, Zinsius C, Wenger A, Bille J, Poirel L, Nordmann P. 2007. Extended-spectrum β-lactamases of the CTX-M type now in Switzerland. Antimicrobial agents and chemotherapy 51:2855-2860. 25. Al-Agamy MH, Shibl AM, Hafez MM, Al-Ahdal MN, Memish ZA, Khubnani H. 2014. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. Annals of Clinical Microbiology and Antimicrobials 13:1-7. 26. Wang X-r, Chen J-c, Yu K, Jiang N, An S-c, Gao Z-c. 2012. Prevalence and characterization of plasmid-mediatedbla ESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniaein patients with pneumonia. Chinese medical journal 125:894-900. 27. Alo M, Anyim C, Igwe J, Elom M. 2012. Presence of extended spectrum β-lactamase (ESBL) E. coli and K. pneumonia isolated from blood cultures of hospitalized patients. Advances in Applied Science Research 3:821-825. 28. Roy S, Mukherjee S, Singh A, Basu S. 2011. CTX-M-9 group extended-spectrum β-lactamases in neonatal stool isolates: Emergence in India. Indian journal of medical microbiology 29:305. 29. Ishii Y, Alba J, Kimura S, Shiroto K, Yamaguchi K. 2005. Evaluation of antimicrobial activity of β-lactam antibiotics using Etest against clinical isolates from 60 medical centres in Japan. International journal of antimicrobial agents 25:296-301. 30. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D. 2005. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. Journal of Antimicrobial Chemotherapy 56:128-132. 31. Mehd SDM, Asghar MS, Kazem SYM, Abdolaziz RL, Zahra R, Sovan AY. 2012. Antimicrobial Resistance Trends Of Klebsiella Spp. Isolated From Patients In Imam Khomeini Hospital. Payavard Salamat 6. 32. Amin A, Ghumro PB, Hussain S, A. H. 2009. Prevalence of antibiotic resistance among clinical isolates of Klebsiella pneumoniae isolated from a tertiary care hospital in Pakistan. Malays J Microbiol 5:81-6. 33. Al Shara MA. 2011. Emerging antimicrobial resistance of Klebsiella pneumonia strains isolated from pediatric patients in jordan. Iraqi J Med 7:29-32. 34. Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH. 2011. Prevalence and genetic characteristics of blaTEM, blaSHV, and blaCTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microbial drug resistance 17:383-388. 35. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D. 2010. Distribution of blaTEM, blaSHV, blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microbial drug resistance 16:49-53. 36. Ranjbar R, Memariani H, Sorouri R. 2017. Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Strains Isolated from Children with Urinary Tract Infections. Arch Pediatr Infect Dis 5:e39000. 37. Abrar S, Ain NU, Liaqat H, Hussain S, Rasheed F, Riaz S. 2019. Distribution of blaCTX− M, blaTEM, blaSHV and blaOXA genes in Extended-spectrum-β-lactamase-producing Clinical isolates: A three-year multi-center study from Lahore, Pakistan. Antimicrobial Resistance and Infection Control 8:1-10. 38. Ahmed MAS, Bansal D, Acharya A, Elmi AA, Hamid JM, Ahmed AMS, Chandra P, Ibrahim E, Sultan AA, Doiphode S. 2016. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrobial resistance and infection control 5:1-6. 39. Effendi MH, Bintari I, Aksono E, Hermawan I. 2018. Detection of blaTEM Gene of Klebsiella pneumoniae Isolated from swab of food-producing animals in East Java. Tropical Animal Science Journal 41:174-178. 40. Ugbo E, Anyamene C, Moses I, Iroha I, Babalola O, Ukpai E, Chukwunwejim C, Egbule C, Emioye A, Okata-Nwali O. 2020. Prevalence of blaTEM, blaSHV, and blaCTX-M genes among extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae of clinical origin. Gene Reports 21:100909. 41. Zhong X-s, Li Y-z, Ge J, Xiao G, Mo Y, Wen Y-q, Liu J-p, Xiong Y-q, Qiu M, Huo S-t. 2020. Comparisons of microbiological characteristics and antibiotic resistance of Klebsiella pneumoniae isolates from urban rodents, shrews, and healthy people. BMC microbiology 20:1-8.
3. Ueber die Schizomyceten bei der acuten fibrösen Pneumonie
4. Klebsiella pneumoniae: Going on the Offense with a Strong Defense
5. Bacterial Etiology and Antibiotic Resistance Patterns in Neonatal Sepsis in Tehran during 2006-2014